会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 9. 发明授权
    • Tape preparation
    • 磁带准备
    • US08354121B2
    • 2013-01-15
    • US12308099
    • 2007-06-07
    • Hiroo MaedaNaoki Ohara
    • Hiroo MaedaNaoki Ohara
    • A61F13/02A61K31/497
    • A61K31/496A61K9/7061
    • It is intended to provide a preparation for percutaneous administration of 2-(4-ethyl-1-piperazinyl)-4-(4-fluoro-phenyl)-5,6,7,8,9,10-hexahydrocycloocta[b]pyridine (Compound A), which inhibits the generation of a metabolite and is capable of continuously maintaining a blood drug level. Specifically, a tape preparation comprising an adhesive layer formed on one surface of a support, characterized in that the adhesive layer contains (1) Compound A or a physiologically acceptable acid addition salt thereof, and (2) an acrylic adhesive, or (1) Compound A or a physiologically acceptable acid addition salt thereof, (2) an acrylic adhesive, and (3) a permeation enhancer is provided.
    • 本发明旨在提供经皮给予2-(4-乙基-1-哌嗪基)-4-(4-氟 - 苯基)-5,6,7,8,9,10-六氢环辛[b]吡啶 (化合物A),其抑制代谢物的产生并能够连续维持血药浓度。 具体而言,包括在载体的一个表面上形成的粘合剂层的胶带制剂,其特征在于,所述粘合剂层包含(1)化合物A或其生理上可接受的酸加成盐,和(2)丙烯酸粘合剂,或(1) 化合物A或其生理上可接受的酸加成盐,(2)丙烯酸粘合剂,和(3)渗透促进剂。